L-dopa pkpd model
Indication: Parkinson's disease
Interactive levodopa PK/PD simulator for Parkinson's disease with immediate- and controlled-release oral profiles and stage-specific motor-response thresholds.
Drug Overview
Clinical Context
- Molecular Target
- Plasma levodopa and motor response
- Drug Class
- Dopamine precursor / antiparkinsonian
- Therapeutic Area
- Neurology
- Indication
- Parkinson's disease
- Route of Administration
- Oral
Model Information
- Model Type
- 1-compartment oral PK with effect-compartment PD
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
Pharmacokinetic Parameters
Additional Parameters
| Parameter | Value |
|---|---|
| pd | {"stage_I":{"E0":144,"Emax":45,"Hill":2,"t12eq_min":133,"EC50_ug_mL":0.2},"stage_II":{"E0":141,"Emax":35,"Hill":5,"t12eq_min":78,"EC50_ug_mL":0.29},"stage_IV":{"E0":117,"Emax":55,"Hill":18,"t12eq_min":20,"EC50_ug_mL":0.94},"stage_III":{"E0":114,"Emax":41,"Hill":7,"t12eq_min":28,"EC50_ug_mL":0.6}} |
| immediate release | {"Ka_h":3.456,"Lag_h":0,"V_F_L":36.746,"CL_F_L_h":37.665} |
| controlled release | {"Ka_h":0.953,"Lag_h":0.84,"V_F_L":76.379,"CL_F_L_h":49.875} |
| entacapone adjustment | {"Lag_add_h":0.1,"Ka_multiplier":0.85,"CL_F_multiplier":0.85} |
| thresholds ug m L | {"switch_on":1.6,"sustained_response":2,"brief_or_no_response":1.2} |
Parameters sourced from published population pharmacokinetic models. Values represent typical population estimates; individual patient parameters may vary.
About This Simulator
This interactive pharmacokinetic simulator for L-dopa allows you to explore concentration-time profiles under different dosing scenarios. The underlying 1-compartment oral PK with effect-compartment PD model characterizes the pharmacokinetics of this dopamine precursor / antiparkinsonian following oral administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration). The pharmacodynamic component links drug exposure to therapeutic or safety endpoints.
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the L-dopa PK simulator?
This is a free, interactive pharmacokinetic simulator for L-dopa used in Parkinson's disease. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does L-dopa belong to?
L-dopa is classified as a Dopamine precursor / antiparkinsonian that targets Plasma levodopa and motor response. It is used in the Neurology therapeutic area.
What route of administration does this model simulate?
This simulator models Oral administration of L-dopa. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a 1-compartment oral PK with effect-compartment PD model. This model characterizes the time-course of drug concentrations following dosing.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
ldopa 2
Parkinson's disease
Ocrevus (Ocrelizumab) PK Simulator
Multiple sclerosis
Phenytoin TDM Simulator
Epilepsy
Carbamazepine TDM Simulator
Epilepsy
DAC
Multiple Sclerosis
Ready to Simulate?
Launch the L-dopa simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community